An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma-Reference-Cited by-同舟云学术

An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma

Published:2021-09 Issue: Volume:154 Page:201-208
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Agulnik Mark^ORCID,Schulte Brian,Robinson Steven^ORCID,Hirbe Angela C.^ORCID,Kozak Kevin^ORCID,Chawla Sant P.,Attia Steven,Rademaker Alfred,Zhang Hui,Abbinanti Susan,Cehic Rasima,Monga Varun^ORCID,Milhem Mohammed,Okuno Scott,Van Tine Brian A.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Emerging opportunities for target discovery in rare cancers;Sharifnia;Cell Chem Biol,2017

2. Angiosarcoma: clinical and molecular insights;Lahat;Ann Surg,2010

3. Clinical outcomes of angiosarcoma: a single institution experience;Kim;Canc Commun,2019

4. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study;Penel;J Clin Oncol,2008

5. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials;Young;Eur J Canc,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and immune pathobiology of human angiosarcoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre;Breast Cancer;2023-12-26

3. Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties;International Journal of Molecular Sciences;2023-12-18

4. Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System;Frontiers in Oncology;2023-10-31

5. The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma;Journal of Clinical Medicine;2023-03-29